Skip to main content
ScholarsBetaWeill Cornell Medicine
This profile is being populated. Some content may not yet be available. See Medicine for additional information.

Clinical research

2 studies

Active

2 studies
  • PI
    A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Adult and Pediatric Subjects With APOL1-mediated Proteinuric Kidney Disease
    PHASE2; PHASE3 · Vertex Pharmaceuticals, Inc. · OPEN TO ACCRUAL (as of 2024)
    Proteinuric Kidney Disease
    NCT05312879
  • PI
    A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals with Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin
    Vertex Pharmaceuticals, Inc. · OPEN TO ACCRUAL (as of 2023)